Latest Ingelheim am Rhein Stories
Significant portion of alliance opportunity will remain unchanged; some countries will transition to exclusive promotion in 2015 INDIANAPOLIS and INGELHEIM, Germany, Oct.
LONDON and BOSTON, October 28, 2014 /PRNewswire/ -- Global top 20 pharma company streamlines R&D IT with cross-domain platform Boehringer Ingelheim,
BONN, Germany, October 14, 2014 /PRNewswire/ -- Rigontec GmbH, a privately held biopharmaceutical company developing RNA-based immunotherapeutics for the treatment of cancer
The Nation’s Premier Annual Physical Activity and Hispanic Family Health Celebration Boehringer Ingelheim Pharmaceuticals, Inc.
The Nation’s Premier Annual Physical Activity and Hispanic Family Health Celebration Dallas, TX (PRWEB) September 02, 2014 On Saturday, September 6,
All Aspects Of Litigation Surrounding The Federal Pradaxa Lawsuits Alleging Boehringer Ingelheim's Blood Thinner Caused Serious Internal Bleeding Have Been Suspended Until Completion Of A
Thousands of Pradaxa Lawsuits Currently Pending in U.S.
Boehringer Ingelheim GmbH, a German pharmaceutical company, recently announced a settlement for approximately 4,000 claims related to injuries and deaths caused by the blood thinner Pradaxa.
German pharmaceutical company Boehringer Ingelheim GmbH has agreed to settle nearly 4,000 claims against the drug company for injuries and deaths caused by the blood thinner Pradaxa.
The Long Island, New York law firm of Rudolph F. X. Migliore, P. C.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.